Oncogenic	B:C0034678
RAS	I:C0034678
regulates	O
long	O
non-coding	I:C3494264
RNA	I:C3494264
Orilnc1	I:C3494264
in	O
human	O
cancer	O
.	O

Oncogenic	O
RAS	I:C0034678
regulates	B:C0017263
long	O
non-coding	I:C3494264
RNA	I:C3494264
Orilnc1	I:C3494264
in	O
human	O
cancer	O
.	O

Oncogenic	O
RAS	I:C0034678
regulates	O
long	B:C3494264
non-coding	I:C3494264
RNA	I:C3494264
Orilnc1	I:C3494264
in	O
human	O
cancer	O
.	O

Oncogenic	O
RAS	I:C0034678
regulates	O
long	O
non-coding	I:C3494264
RNA	I:C3494264
Orilnc1	I:C3494264
in	O
human	B:C0086418
cancer	O
.	O

Oncogenic	O
RAS	I:C0034678
regulates	O
long	O
non-coding	I:C3494264
RNA	I:C3494264
Orilnc1	I:C3494264
in	O
human	O
cancer	B:C0007097
.	O

RAS	B:C0034678
and	O
its	O
downstream	O
cascades	I:C0017337
transmit	O
cellular	O
signals	I:C0037083
resulting	O
in	O
increased	O
transcription	O
of	I:C0040649
genes	I:C0040649
involved	O
in	O
cell	O
growth	I:C0007595
and	O
division	O
.	O

RAS	O
and	O
its	O
downstream	B:C0017337
cascades	I:C0017337
transmit	O
cellular	O
signals	I:C0037083
resulting	O
in	O
increased	O
transcription	O
of	I:C0040649
genes	I:C0040649
involved	O
in	O
cell	O
growth	I:C0007595
and	O
division	O
.	O

RAS	O
and	O
its	O
downstream	O
cascades	I:C0017337
transmit	O
cellular	B:C0037083
signals	I:C0037083
resulting	O
in	O
increased	O
transcription	O
of	I:C0040649
genes	I:C0040649
involved	O
in	O
cell	O
growth	I:C0007595
and	O
division	O
.	O

RAS	O
and	O
its	O
downstream	O
cascades	I:C0017337
transmit	O
cellular	O
signals	I:C0037083
resulting	O
in	O
increased	O
transcription	B:C0040649
of	I:C0040649
genes	I:C0040649
involved	O
in	O
cell	O
growth	I:C0007595
and	O
division	O
.	O

RAS	O
and	O
its	O
downstream	O
cascades	I:C0017337
transmit	O
cellular	O
signals	I:C0037083
resulting	O
in	O
increased	O
transcription	O
of	I:C0040649
genes	I:C0040649
involved	O
in	O
cell	B:C0007595
growth	I:C0007595
and	O
division	O
.	O

RAS	O
and	O
its	O
downstream	O
cascades	I:C0017337
transmit	O
cellular	O
signals	I:C0037083
resulting	O
in	O
increased	O
transcription	O
of	I:C0040649
genes	I:C0040649
involved	O
in	O
cell	O
growth	I:C0007595
and	O
division	B:C0007590
.	O

Protein	B:C3839127
-	I:C3839127
coding	I:C3839127
gene	I:C3839127
targets	O
of	O
RAS	O
signaling	I:C1514731
have	O
been	O
characterized	O
extensively	O
,	O
but	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
regulated	O
by	O
these	O
processes	O
have	O
not	O
.	O

Protein	O
-	I:C3839127
coding	I:C3839127
gene	I:C3839127
targets	O
of	O
RAS	B:C1514731
signaling	I:C1514731
have	O
been	O
characterized	O
extensively	O
,	O
but	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
regulated	O
by	O
these	O
processes	O
have	O
not	O
.	O

Protein	O
-	I:C3839127
coding	I:C3839127
gene	I:C3839127
targets	O
of	O
RAS	O
signaling	I:C1514731
have	O
been	O
characterized	O
extensively	O
,	O
but	O
long	B:C3494264
non-coding	I:C3494264
RNAs	I:C3494264
(	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
regulated	O
by	O
these	O
processes	O
have	O
not	O
.	O

Protein	O
-	I:C3839127
coding	I:C3839127
gene	I:C3839127
targets	O
of	O
RAS	O
signaling	I:C1514731
have	O
been	O
characterized	O
extensively	O
,	O
but	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
long	B:C3494264
non-coding	I:C3494264
RNAs	I:C3494264
)	O
regulated	O
by	O
these	O
processes	O
have	O
not	O
.	O

Protein	O
-	I:C3839127
coding	I:C3839127
gene	I:C3839127
targets	O
of	O
RAS	O
signaling	I:C1514731
have	O
been	O
characterized	O
extensively	O
,	O
but	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
regulated	B:C0017263
by	O
these	O
processes	O
have	O
not	O
.	O

Using	O
a	O
custom	O
-	O
designed	O
lncRNA	O
microarray	O
,	O
we	O
identified	O
the	O
lncRNA	B:C3494264
Orilnc1	I:C3494264
as	O
a	O
genetic	O
target	O
of	O
RAS	O
that	O
is	O
critical	O
for	O
RAS	O
oncogenicity	O
.	O

Using	O
a	O
custom	O
-	O
designed	O
lncRNA	O
microarray	O
,	O
we	O
identified	O
the	O
lncRNA	O
Orilnc1	I:C3494264
as	O
a	O
genetic	O
target	O
of	O
RAS	B:C0034678
that	O
is	O
critical	O
for	O
RAS	O
oncogenicity	O
.	O

Using	O
a	O
custom	O
-	O
designed	O
lncRNA	O
microarray	O
,	O
we	O
identified	O
the	O
lncRNA	O
Orilnc1	I:C3494264
as	O
a	O
genetic	O
target	O
of	O
RAS	O
that	O
is	O
critical	O
for	O
RAS	B:C0034678
oncogenicity	O
.	O

Using	O
a	O
custom	O
-	O
designed	O
lncRNA	O
microarray	O
,	O
we	O
identified	O
the	O
lncRNA	O
Orilnc1	I:C3494264
as	O
a	O
genetic	O
target	O
of	O
RAS	O
that	O
is	O
critical	O
for	O
RAS	O
oncogenicity	B:C3828709
.	O

Orilnc1	B:C3494264
expression	O
was	O
regulated	O
by	O
RAS	O
-	I:C0037080
RAF	I:C0037080
-	I:C0037080
MEK	I:C0037080
-	I:C0037080
ERK	I:C0037080
signaling	I:C0037080
via	O
the	O
transcription	O
factor	I:C3888349
AP1	I:C3888349
.	O

Orilnc1	O
expression	B:C0017262
was	O
regulated	O
by	O
RAS	O
-	I:C0037080
RAF	I:C0037080
-	I:C0037080
MEK	I:C0037080
-	I:C0037080
ERK	I:C0037080
signaling	I:C0037080
via	O
the	O
transcription	O
factor	I:C3888349
AP1	I:C3888349
.	O

Orilnc1	O
expression	O
was	O
regulated	B:C0017263
by	O
RAS	O
-	I:C0037080
RAF	I:C0037080
-	I:C0037080
MEK	I:C0037080
-	I:C0037080
ERK	I:C0037080
signaling	I:C0037080
via	O
the	O
transcription	O
factor	I:C3888349
AP1	I:C3888349
.	O

Orilnc1	O
expression	O
was	O
regulated	O
by	O
RAS	B:C0037080
-	I:C0037080
RAF	I:C0037080
-	I:C0037080
MEK	I:C0037080
-	I:C0037080
ERK	I:C0037080
signaling	I:C0037080
via	O
the	O
transcription	O
factor	I:C3888349
AP1	I:C3888349
.	O

Orilnc1	O
expression	O
was	O
regulated	O
by	O
RAS	O
-	I:C0037080
RAF	I:C0037080
-	I:C0037080
MEK	I:C0037080
-	I:C0037080
ERK	I:C0037080
signaling	I:C0037080
via	O
the	O
transcription	B:C3888349
factor	I:C3888349
AP1	I:C3888349
.	O

Orilnc1	B:C3494264
was	O
highly	O
expressed	O
in	O
BRAF	O
-	I:C1511021
mutant	I:C1511021
cancers	O
such	O
as	O
melanoma	O
.	O

Orilnc1	O
was	O
highly	O
expressed	B:C0017262
in	O
BRAF	O
-	I:C1511021
mutant	I:C1511021
cancers	O
such	O
as	O
melanoma	O
.	O

Orilnc1	O
was	O
highly	O
expressed	O
in	O
BRAF	B:C1511021
-	I:C1511021
mutant	I:C1511021
cancers	O
such	O
as	O
melanoma	O
.	O

Orilnc1	O
was	O
highly	O
expressed	O
in	O
BRAF	O
-	I:C1511021
mutant	I:C1511021
cancers	B:C0007097
such	O
as	O
melanoma	O
.	O

Orilnc1	O
was	O
highly	O
expressed	O
in	O
BRAF	O
-	I:C1511021
mutant	I:C1511021
cancers	O
such	O
as	O
melanoma	B:C0025202
.	O

Silencing	B:C0598496
of	O
Orilnc1	O
blocked	O
tumor	O
cell	I:C0596290
proliferation	I:C0596290
and	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Silencing	O
of	O
Orilnc1	B:C3494264
blocked	O
tumor	O
cell	I:C0596290
proliferation	I:C0596290
and	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Silencing	O
of	O
Orilnc1	O
blocked	O
tumor	B:C0596290
cell	I:C0596290
proliferation	I:C0596290
and	O
growth	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Silencing	O
of	O
Orilnc1	O
blocked	O
tumor	O
cell	I:C0596290
proliferation	I:C0596290
and	O
growth	B:C0007595
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Silencing	O
of	O
Orilnc1	O
blocked	O
tumor	O
cell	I:C0596290
proliferation	I:C0596290
and	O
growth	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
.	O

Additionally	O
,	O
Orilnc1	B:C3494264
blockade	O
reduced	O
expression	O
of	O
Cyclin	O
E1	I:C1259807
and	O
induced	O
G1/S	O
cell	I:C1517339
cycle	I:C1517339
arrest	I:C1517339
in	O
tumor	O
cells	I:C0597032
.	O

Additionally	O
,	O
Orilnc1	O
blockade	O
reduced	O
expression	B:C1171362
of	O
Cyclin	O
E1	I:C1259807
and	O
induced	O
G1/S	O
cell	I:C1517339
cycle	I:C1517339
arrest	I:C1517339
in	O
tumor	O
cells	I:C0597032
.	O

Additionally	O
,	O
Orilnc1	O
blockade	O
reduced	O
expression	O
of	O
Cyclin	B:C1259807
E1	I:C1259807
and	O
induced	O
G1/S	O
cell	I:C1517339
cycle	I:C1517339
arrest	I:C1517339
in	O
tumor	O
cells	I:C0597032
.	O

Additionally	O
,	O
Orilnc1	O
blockade	O
reduced	O
expression	O
of	O
Cyclin	O
E1	I:C1259807
and	O
induced	O
G1/S	B:C1517339
cell	I:C1517339
cycle	I:C1517339
arrest	I:C1517339
in	O
tumor	O
cells	I:C0597032
.	O

Additionally	O
,	O
Orilnc1	O
blockade	O
reduced	O
expression	O
of	O
Cyclin	O
E1	I:C1259807
and	O
induced	O
G1/S	O
cell	I:C1517339
cycle	I:C1517339
arrest	I:C1517339
in	O
tumor	B:C0597032
cells	I:C0597032
.	O

Taken	O
together	O
,	O
our	O
results	O
identify	O
Orilnc1	B:C3494264
as	O
a	O
novel	O
,	O
non-protein	O
mediator	O
of	O
RAS	O
/	I:C2265359
RAF	I:C2265359
activation	I:C2265359
which	O
may	O
serve	O
as	O
a	O
therapeutic	O
target	O
in	O
RAS	O
/	I:C0007097
RAF	I:C0007097
-	I:C0007097
driven	I:C0007097
cancers	I:C0007097
.	O

Taken	O
together	O
,	O
our	O
results	O
identify	O
Orilnc1	O
as	O
a	O
novel	O
,	O
non-protein	O
mediator	O
of	O
RAS	B:C2265359
/	I:C2265359
RAF	I:C2265359
activation	I:C2265359
which	O
may	O
serve	O
as	O
a	O
therapeutic	O
target	O
in	O
RAS	O
/	I:C0007097
RAF	I:C0007097
-	I:C0007097
driven	I:C0007097
cancers	I:C0007097
.	O

Taken	O
together	O
,	O
our	O
results	O
identify	O
Orilnc1	O
as	O
a	O
novel	O
,	O
non-protein	O
mediator	O
of	O
RAS	O
/	I:C2265359
RAF	I:C2265359
activation	I:C2265359
which	O
may	O
serve	O
as	O
a	O
therapeutic	O
target	O
in	O
RAS	B:C0007097
/	I:C0007097
RAF	I:C0007097
-	I:C0007097
driven	I:C0007097
cancers	I:C0007097
.	O

